A New Front in Myeloma Therapy and an Emerging Complication in Blood Bank Testing

12pm IST | 4:30pm AEST | 8:30am CEST | 2:30am ET | 7:30am UTC

Level of Instruction: Intermediate

Language: English

Chairperson:

Dr. Rajesh Sawant
Consultant, Transfusion Medicine & Histocompatibility & Immunogenetics
Kokilaben Dhirubhai Ambani Hospital
Mumbai, India

Speaker:

Dr. Rasika Setia
Associate Director & HOD, Transfusion Medicine,
BLK Max Super Speciality Hospital Pusa Road,
New Delhi, India

Webinar Objectives:

• The use of monoclonal therapies are likely to increase in frequency as more patients are successfully treated and more therapies are approved.
• Mechanism of action of Daratumumab - Guidance from AABB for the same.
• Discuss about what kind of issues we are facing during serological investigations and how to overcome them.(Emerging Complications & Cause of Interference)
• Mitigation strategies for these therapies, while effective, are time consuming and inefficient.
• Define, how we can reduce interference of the monoclonal therapies in pre-transfusion testing through Capture® Technology (Strategies for Resolving Interferences).

Register Now!